Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.

@article{Sandoval2007SerumPP,
  title={Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.},
  author={John A. Sandoval and Katharyn E Turner and Derek J. Hoelz and Frederick J. Rescorla and Robert J. Hickey and Linda H. Malkas},
  journal={The Journal of surgical research},
  year={2007},
  volume={142 2},
  pages={268-74}
}
INTRODUCTION Development of early detection assays for advanced stage neuroblastoma (NB) remains elusive. We have previously shown that serum protein profiling technologies can differentiate healthy from NB children. As various sources of patient related bias exist in serum proteins, we hypothesized a well controlled animal model may provide a better method… CONTINUE READING